Integrant
About Integrant
Integrant is a Medtech startup based in Sydney, Australiasince 2015. The company reached Series A stage in April 2026 with a null round led by institutional investors.
Integrant is a Sydney-based biotechnology company specialising in the integration of regenerative medical therapies with orthopaedic applications. Founded in 2015, the company develops AI-enhanced solutions for bone healing, fracture management, and cartilage regeneration, with a flagship intra-articular injection therapy targeting meniscus cartilage repair in patients with osteoarthritis. Its proprietary Frame IT technology and advanced biologic processing systems span foot and ankle, spine, and knee applications. Integrant has closed a Series A capital raise and is advancing toward a Nasdaq listing under the ticker symbol INGT, planned for November 2026, positioning itself as a global player in AI-enhanced regenerative medicine.
Integrant Funding Rounds Timeline
1 rounds · since 2015
| Round | Date | Amount | Valuation | Lead investor | Co-investors |
|---|---|---|---|---|---|
| Series A | April 2026 | Undisclosed | — | — | — |
Recent news about Integrant
Questions about Integrant
How much has Integrant raised?
Integrant has raised null across 1 funding round since 2015.
When was Integrant's last funding round?
Integrant's most recent round was a null Series A in April 2026.
Where is Integrant headquartered?
Integrant is headquartered in Sydney, Australia, and was founded in 2015.